|
English
|
正體中文
|
简体中文
|
2809353
|
|
???header.visitor??? :
26908728
???header.onlineuser??? :
524
???header.sponsordeclaration???
|
|
|
|
???tair.name??? >
???browser.page.title.author???
|
"tsang janice"???jsp.browse.items-by-author.description???
Showing items 1-2 of 2 (1 Page(s) Totally)
1
View [10|25|50] records per page
| 臺大學術典藏 |
2022-04-15T02:29:49Z |
Afatinib alone and in combination with vinorelbine or paclitaxel, in patients with HER2-positive breast cancer who failed or progressed on prior trastuzumab and/or lapatinib (LUX-Breast 2): an open-label, multicenter, phase II trial
|
Hickish, Tamas; Mehta, Ajay; Liu, Mei-Ching; CHIUN-SHENG HUANG; Arora, Rajendra Singh; Chang, Yuan-Ching; Yang, Youngsen; Vladimirov, Vladimir; Jain, Minish; Tsang, Janice; Pemberton, Karine; Sadrolhefazi, Behbood; Jin, Xidong; Tseng, Ling-Ming |
| 國立臺灣大學 |
2012 |
LUX-breast 2: Phase II, open-label study of oral afatinib in HER2-overexpressing metastatic breast cancer (MBC) patients (pts) who progressed on prior trastuzumab (T) and/or lapatanib (L)
|
Hickish, Tamas; Tseng, Ling-Ming; Mehta, Ajay O.; Tsang, Janice; Kovalenko, Nadezhda; Udovitsa, Dmitry; Pelling, Katy; Uttenreuther-Fischer, Martina Maria; Huang, Chiun-Sheng; 黃俊升 |
Showing items 1-2 of 2 (1 Page(s) Totally)
1
View [10|25|50] records per page
|
